Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio-Techne Corp TECH

Healthcare  —  Biotechnology
72.61 0.04 0.06% as of 25 Sep
Market cap
$11.4B
P/E
62.1×
S&P 500 Member Dividend Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Bio-Techne Corp (TECH) Book value per share

Bio-Techne Corp's book value per share at the end of fiscal 2026 was 13.5×, up 11.0% from 12.2× in fiscal 2025. Over the past ten years it has ranged from 5.7× (fiscal 2015) to 13.5× (fiscal 2026) — the current reading is the highest in ten years. Bio-Techne Corp ranks 51st of 614 Biotechnology companies by book value per share.

Book value per share, annual

Annual

Period Book value per share Change
FY2026 13.5× 10.97%
FY2025 12.2× (7.14%)
FY2024 13.1× 4.85%
FY2023 12.5× 15.38%
FY2022 10.8× 6.96%
FY2021 10.1× 12.16%
FY2020 9.0× 17.19%
FY2019 7.7× 7.15%
FY2018 7.2× 13.13%
FY2017 6.4× 7.66%

Quarterly

Period Book value per share Change
Jun 2026 13.5× 1.33%
Mar 2026 13.3× 3.37%
Dec 2025 12.9× 2.05%
Sep 2025 12.6× 3.81%
42 more quarters

Against its own ten years

Low 5.7× High 13.5×
Ten-year median 9.6×
Current reading's percentile 100

Book value per share against peers

Company Book value per share
KRYS Krystal Biotech, Inc. compare 46.0×
BMRN BioMarin Pharmaceutical Inc. compare 32.7×
MDGL Madrigal Pharmaceuticals, Inc. compare 18.0×
TECH Bio-Techne Corp 13.5×
CORT Corcept Therapeutics Incorporated compare 6.7×
AXSM Axsome Therapeutics, Inc. compare 1.6×
HALO Halozyme Therapeutics, Inc. compare 1.2×
SMMT Summit Therapeutics PLC compare 0.8×
BBIO BridgeBio Pharma, Inc. compare −12.8×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on TECH